Stokar J, Szalat A. Response to Letter to the Editor from Kawaguchi: 'Cardiovascular Safety of Romosozumab vs. PTH Analogs for Osteoporosis Treatment: a Propensity Score Matched Cohort Study. J Clin Endocrinol Metab 2024 May 20:dgae348. doi: 10.1210.
PMID: 38767110